Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2025-12-26 @ 1:14 PM
Study NCT ID:
NCT05412459
Status:
COMPLETED
Last Update Posted:
2023-03-06
First Post:
2022-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy
Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2022-06-02
First Submit QC Date:
None
Study First Post Date:
2022-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-03
Last Update Post Date:
2023-03-06
Last Update Post Date Type:
ACTUAL